A heartbreaking diagnosis has left a young Devon father fighting for time – and a glimmer of hope. Elliot MacDonald, 35, was given just 12-18 months to live after being diagnosed with an aggressive grade four glioblastoma brain tumour. His prognosis is all too familiar for many who have lost loved ones to this devastating disease.
Elliot's story began in late May when he noticed strange difficulties with everyday tasks, such as using his phone and writing. An emergency surgery at Derriford Hospital in Plymouth followed the discovery of a mass on his brain. His wife Erica and their two young children – aged one and five – are now navigating the complex aftermath of this diagnosis.
Desperate to explore all options, the family has turned to research potential treatments not currently available through the NHS. These cutting-edge therapies, including immunotherapies, offer a glimmer of hope but come with a crucial caveat: they have yet to be proven in UK clinical trials, notes Dr Ola Rominyi, a clinical lecturer in neurosurgery at the University of Sheffield.
Elliot's case highlights a broader concern – that brain cancer research and funding are severely under-resourced. As Dr Simon Newman from the Brain Tumour Charity explains, brain tumours are the biggest cancer killer of children and adults under 40, yet receive a paltry 3% of national cancer research funding. The Department of Health has invested £25 million to advance brain cancer treatments, but campaigners argue that more extensive research and clinical trials within the UK are needed to identify new effective therapies.
The outpouring of support from Elliot's friends and family has been truly remarkable – their £150,000 fundraising campaign reached its target in just 48 hours. This generous donation will allow him to access non-NHS funded treatments, a chance not available to all patients facing similar circumstances.